Table A4:
Number of Studies (Design) | Risk of Bias | Inconsistency | Indirectness | Imprecision | Publication Bias | Upgrade Considerations | Quality |
---|---|---|---|---|---|---|---|
Glucose variability | |||||||
1 (RCT, adults)33 | No serious limitations | Very serious limitations (−2)a | No serious limitations | No serious limitations | Undetected | None | ⊕⊕ Low |
Time in target glucose range (3.9–10.0 mmol/L [70–180 mg/dL]) in hours, within 24 hours | |||||||
1 (RCT, adults)33 | No serious limitations | Unknown | No serious limitations | Very serious limitations (−2)b | Undetected | None | ⊕⊕ Low |
Time above target glucose range (> 13.3 mmol/L) in hours, within 24 hours | |||||||
1 (RCT, adults)33 | No serious limitations | Unknown | No serious limitations | Very serious limitations (−2)b | Undetected | None | ⊕ Low |
Time in hypoglycemia (< 3.9 mmol/L [70 mg/dL] within 24 hours) | |||||||
1 (RCT, adults)33 | No serious limitations | Unknown | Serious limitations (−1)c | No serious limitations | Undetected | None | ⊕⊕⊕ Moderate |
Time in hypoglycemia (< 3.9 mmol/L [70 mg/dL] at night [2300–0600h] within 7 hours) | |||||||
1 (RCT, adults)33 | No serious limitations | Unknown | Serious limitations (−1)c | No serious limitations | Undetected | None | ⊕⊕⊕ Moderate |
Hypoglycemia events (< 3.9 mmol/L [70 mg/dL] within 24 hours) | |||||||
1 (RCT, adults)33 | No serious limitations | Unknown | Serious limitations (−1)c | No serious limitations | Undetected | None | ⊕⊕⊕ Moderate |
Severe hypoglycemia events | |||||||
1 (RCT, adults)33 | No serious limitations | Unknown | Serious limitations (−1)c | Very serious limitations (−2)d | Undetected | None | ⊕ Very low |
Quality of life | |||||||
1 (RCT, adults)33 | No serious limitations | No serious limitations | Very serious limitations (−2)j | No serious limitations | Undetected | None | ⊕⊕ Lowh |
1 (observational, adults)48 | Serious limitations (−1)e | No serious limitations | No serious limitations | Undetected | None | ||
Glycated hemoglobin levels | |||||||
1 (RCT, adults)33 | Serious limitations (−1)f | No serious limitations | Serious limitations (−1)g | No serious limitations | Undetected | None | ⊕⊕ Low |
Device-related adverse events | |||||||
1 (RCT, adults)33 | No serious limitations | Unknown | Serious limitations (−1)i | Very serious limitations (−2)d | Undetected | None | ⊕ Very low |
Abbreviations: GRADE, Grading of Recommendations Assessment, Development, and Evaluation; RCT, randomized controlled trial.
Inconsistency across several scales of glucose variability.
Confidence intervals are too wide, covering values that are consistent with null, in favour of flash glucose monitoring, and in favour of self-monitoring of blood glucose.
Uncertainty on whether the difference is big enough to affect clinical outcomes.
Data too sparse. No meaningful comparative safety inference can be made.
Duration of study not given. Potential for bias if length of follow-up differs.
Data imputed using the last observation carried forward.
Generalizability depends on the age distribution of target population.
Conclusion on certainty of evidence is based on the better-quality study.
Sample size for assessing outcome is too small. Findings might not reflect target population.
Some questions in the survey do not seem to relate to use of flash glucose monitoring or self-monitoring of blood glucose.